- Published at
- by manilatimes.net
positive
positive
News for Aclaris Therapeutics, Inc. (ACRS)
- Published at
- by gurufocus.com
positivepositiveNew Publication Highlights Unique Properties of ATI-2138, a Potent and Selective Inhibitor of ITK and JAK3
- Data Generated to Date Support Potential for Aclaris' ATI-2138 to Impact Several Human Inflammatory Diseases - WAYNE, Pa., Feb. 12, 2025 (GLOBE NEWSWIRE)- Published at
- by gurufocus.com
positivepositiveAclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WAYNE, Pa., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. ( ACRS) (the ”Company” or ”Aclaris”), a clinical-stage biopharmaceutical comp- Published at
- by gurufocus.com
mixedmixedBurning Rock Biotech (BNR) Stock Plummets Amidst Broader Industry Decline
Burning Rock Biotech (BNR) experienced a significant stock drop of 5.02%, with shares priced at $6.25 and a trading volume of 4,410 shares. The stock's turnover- Published at
- by benzinga.com
positivepositiveThis Weyerhaeuser Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday - GCM Grosvenor (NASDAQ:GCMG), Aclaris Therapeutics (NASDAQ:ACRS)
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please ...- Published at
- by gurufocus.com
positivepositiveAclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WAYNE, Pa., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. ( ACRS)(the ”Company” or ”Aclaris”), a clinical-stage biopharmaceutical compa- Published at
- by manilatimes.net
positivepositive- Published at
- by gurufocus.com
positivepositiveAclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
WAYNE, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. ( ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug- Published at
- by gurufocus.com
positivepositiveRock Springs Capital Management LP Increases Stake in Aclaris Therapeutics Inc
On November 18, 2024, Rock Springs Capital Management LP (Trades, Portfolio) executed a significant transaction involving Aclaris Therapeutics Inc. The firm add- Published at
- by gurufocus.com
positivepositiveInsider Buying: Anand Mehra Acquires Shares in Aclaris Therapeutics Inc (ACRS)
On November 19, 2024, [Anand Mehra](https://www.gurufocus.com/insider/29172/anand-mehra), a Director at Aclaris Therapeutics Inc, purchased 666,666 shares of th- Published at
- by seekingalpha.com
negativenegativeAclaris upgraded to overweight by Cantor on in-licensing deal (NASDAQ:ACRS)
Cantor has upgraded Aclaris (ACRS) to overweight, citing the company's in-licensing of two drug candidates from China’s Biosion and concurrent equity raise. Read more here.- Published at
- by seekingalpha.com
positivepositiveAclaris stock soars for second day on licensing deal, analyst upgrades (NASDAQ:ACRS)
Aclaris (ACRS) soared 60% Tuesday, the day after the company announced it was licensing two drug candidates, prompting upgrades by Piper Sandler, BTIG, Jefferies and Leerink.- Published at
- by globenewswire.com
mixedmixedGlobal Alopecia Treatment Market is Anticipated to Surpass ~USD 4 Billion by 2030 | DelveInsight
The growing demand for alopecia treatments is mainly driven by the rising global prevalence of alopecia, influenced by various factors, as well as...- Published at
- by gurufocus.com
mixedmixedAWH Stock Plummets 6.19% Amid Weak Financial Performance
Annette Insurance (AWH) experienced a significant stock drop, falling 6.19%. The stock is currently priced at $0.910 per share with a trading volume of 82,577 s- Published at
- by globenewswire.com
mixedmixedAlopecia Treatment Market Size Expected to Reach USD 20.70 Billion by 2032 with 10.48% CAGR – SNS Insider
As Per SNS Insider, Alopecia Treatment Market Growth is Driven by Rising Demand for Hair Restoration Products, and Technological Advancements....- Published at
- by benzinga.com
positivepositiveAclaris Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying - Branchout Food (NASDAQ:BOF)
The Dow Jones index closed higher by more than 100 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the ...- Published at
- by rttnews.com
mixedmixedPre-market Movers: TMCI, DV, NCI, ZI, INOD…
Florida-based medical technology company Treace Medical Concepts, Inc. (TMCI) is down over 59% in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.- Published at
- by globenewswire.com
mixedmixedPrelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
First-in-class IV SMARCA2 degrader, PRT3789 and potentially best-in-class CDK9 inhibitor, PRT2527 remain on track to generate initial proof-of-concept data...- Published at
- by benzinga.com
mixedmixedWhy CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday’s Mid-Day Session - Archer-Daniels Midland (NYSE:ADM), Aclaris Therapeutics (NASDAQ:ACRS)
Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session. B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the price target from $2.1 to $2. CommScope shares dipped 6.9% to $2.2150 on Monday.- Published at
- by benzinga.com
mixedmixedWhy SentinelOne Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket - Aclaris Therapeutics (NASDAQ:ACRS), Abits Group (NASDAQ:ABTS)
Shares of SentinelOne, Inc. (NYSE: S) rose sharply in pre-market trading after the company reported stronger-than-expected results for its third quarter and raised its annual revenue outlook.